SCHEMBL25502393

SCHEMBL25502393

CNC(=O)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2cc1C

nearest known ligand 0.95

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 19/20 0.95
▸ MET P08581 12/20 0.81
▸ MERTK Q12866 10/20 0.79
▸ AURKA O14965 1/20 0.73
▸ RIPK2 O43353 1/20 0.73
▸ ABCB11 O95342 1/20 0.73
▸ ABL1 P00519 1/20 0.73
▸ EGFR P00533 1/20 0.73
▸ ERBB2 P04626 1/20 0.73
▸ NTRK1 P04629 1/20 0.73
▸ LCK P06239 1/20 0.73
▸ PGR P06401 1/20 0.73
▸ LYN P07948 1/20 0.73
▸ RET P07949 1/20 0.73
▸ CHRM2 P08172 1/20 0.73
▸ HCK P08631 1/20 0.73
▸ ADRA2A P08913 1/20 0.73
▸ ADORA3 P0DMS8 1/20 0.73
▸ KIT P10721 1/20 0.73
▸ CHRM1 P11229 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21201065 0.97 AXL (1.00) AXLMETMERTKAURKARIPK2
Zanzalintinib SCHEMBL21200856 0.90 AXL (1.00) AXLMETMERTKAURKARIPK2
Zanzalintinib SCHEMBL29378531 0.90 AXL (1.00) AXLMETMERTKAURKARIPK2
SCHEMBL21200981 0.90 AXL (0.81) AXLMETMERTKAURKARIPK2
SCHEMBL21200644 0.90 AXL (0.81) AXLMETMERTKAURKARIPK2
SCHEMBL22766276 0.90 AXL (0.81) AXLMETMERTKAURKARIPK2
SCHEMBL21201281 0.90 AXL (1.00) AXLMETMERTKAURKARIPK2
SCHEMBL21201056 0.88 AXL (0.85) AXLMETMERTKAURKARIPK2
SCHEMBL21201024 0.88 AXL (0.86) AXLMETMERTKAURKARIPK2
SCHEMBL21201060 0.88 AXL (1.00) AXLMETMERTKAURKARIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081253-A1 COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS EXELIXIS, INC. (US) 2023-05-11 — — WO disclosed
Send feedback